TD Asset Management »

Cullinan Oncology shares owned by TD Asset Management

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6M 114k 14.21
2021-03-31 $781k 19k 41.68

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Cibc Cad (CM)
Broadcom (AVGO)
Agnico (AEM)
Canadian Natural Resources (CNQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Suncor Energy (SU)
Amazon (AMZN)

View all positions for TD Asset Management

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Vanguard Group
Kynam Capital Management
Vanguard Capital Management
Blue Owl Capital Holdings
State Street Corporation
Affinity Asset Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Siren
Nextech Invest

View all funds holding Cullinan Oncology